StockCIK 1770787

10x Genomics, Inc. (TXG): Insider Trades and Fund Holdings

In the past 12 months, 10x Genomics, Inc. insiders reported 0 open-market purchases worth $0 and 12 sales worth $12.2M; 7 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$12.2MSold by insiders, 12 months

3Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 24, 2026.

Recent TXG insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 24	Sep 22	Serge SaxonovCEO	CEO	▼ SELL10b5-1	25,000	81.22	$2.03M	−2.3%	Form 4 ↗
Sep 24	Sep 22	Shehnaaz SulimanDirector	Director	▼ SELL10b5-1	5,723	81.19	$465K	−19%	Form 4 ↗
Sep 11	Sep 9	Adam TaichCFO	CFO	▼ SELL10b5-1	46,388	64.57	$3.00M	−13%	Form 4 ↗
Sep 8	Sep 3	John R. StuelpnagelDirector	Director	▼ SELL	20,000	61.75	$1.24M	−5.7%	Form 4 ↗
Aug 28	Aug 26	Serge SaxonovCEO	CEO	▼ SELL10b5-1	10,486	63.69	$668K	−1.0%	Form 4 ↗
Aug 26	Aug 24	Serge SaxonovCEO	CEO	▼ SELL	18,545	63.02	$1.17M	−1.7%	Form 4 ↗
Aug 26	Aug 24	Adam TaichCFO	CFO	▼ SELL	17,166	63.02	$1.08M	−4.5%	Form 4 ↗
Aug 26	Aug 24	Benjamin J. HindsonSee Remarks	See Remarks	▼ SELL	13,818	63.02	$871K	−2.8%	Form 4 ↗
Aug 26	Aug 24	Shehnaaz SulimanDirector	Director	▼ SELL10b5-1	2,207	63.65	$140K	−7.0%	Form 4 ↗
Aug 17	Aug 13	Sarah A. TeichmannDirector	Director	▼ SELL10b5-1	5,278	57.29	$302K	−15%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

All 12 TXG insider trades →

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Serge Saxonov	CEO	$0	3	$3.87M	Sep 24, 2026
Shehnaaz Suliman	Director	$0	2	$605K	Sep 24, 2026
Adam Taich	CFO	$0	2	$4.08M	Sep 11, 2026
John R. Stuelpnagel	Director	$0	2	$2.39M	Sep 8, 2026
Benjamin J. Hindson	See Remarks	$0	1	$871K	Aug 26, 2026
Sarah A. Teichmann	Director	$0	2	$432K	Aug 17, 2026

Tracked funds that report TXG

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	802,039	$30.8M	0.04%	▼ −20.5%
Bridgewater Associates	Q2 2026	13,375	$513K	0.00%	▼ −61.9%
Duquesne Family Office	Q2 2026	403,100	$15K	0.35%	▲ New

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →